Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Archives of Biochemistry and Biophysics
|
August 2, 2003
The many faces of c-MYC
Stella Pelengaris, Mike Khan
Expert Opinion on Therapeutic Targets
|
September 23, 2003
The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth
Stella Pelengaris, Mike Khan
Nature Reviews. Cancer
|
October 3, 2002
c-MYC: more than just a matter of life and death
Stella Pelengaris, Mike Khan, Gerard Evan
The Journal of Applied Laboratory Medicine
|
February 25, 2021
Cascade Screening for Familial Hypercholesterolemia: PCR Methods with Melting-Curve Genotyping for the Targeted Molecular Detection of Apolipoprotein B and LDL Receptor Gene Mutations to Identify Affected Relatives
Sarojini Pandey, Michaela Leider, Mike Khan, et al.
Frontiers in Pharmacology
|
July 28, 2018
Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
Maria Mytilinaiou, Ioannis Kyrou, Mike Khan, et al.
Infection and Immunity
|
September 30, 2015
CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection
Marina Durward-Diioia, Jerome Harms, Mike Khan, et al.
Infection and Immunity
|
May 9, 2018
Brucella Peptide Cross-Reactive Major Histocompatibility Complex Class I Presentation Activates SIINFEKL-Specific T Cell Receptor-Expressing T Cells
Jerome S Harms, Mike Khan, Cherisse Hall, et al.
Plos Pathogens
|
December 17, 2013
Brucella induces an unfolded protein response via TcpB that supports intracellular replication in macrophages
Judith A Smith, Mike Khan, Diogo D Magnani, et al.
Cancers
|
October 29, 2020
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study
Beate Schultheis, Dirk Strumberg, Jan Kuhlmann, et al.
Annals of Clinical Biochemistry
|
January 10, 2016
Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays
Anne Reiman, Sarojini Pandey, Kate L Lloyd, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Archives of Biochemistry and Biophysics
|
August 2, 2003
The many faces of c-MYC
Stella Pelengaris, Mike Khan
Expert Opinion on Therapeutic Targets
|
September 23, 2003
The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth
Stella Pelengaris, Mike Khan
Nature Reviews. Cancer
|
October 3, 2002
c-MYC: more than just a matter of life and death
Stella Pelengaris, Mike Khan, Gerard Evan
The Journal of Applied Laboratory Medicine
|
February 25, 2021
Cascade Screening for Familial Hypercholesterolemia: PCR Methods with Melting-Curve Genotyping for the Targeted Molecular Detection of Apolipoprotein B and LDL Receptor Gene Mutations to Identify Affected Relatives
Sarojini Pandey, Michaela Leider, Mike Khan, et al.
Frontiers in Pharmacology
|
July 28, 2018
Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management
Maria Mytilinaiou, Ioannis Kyrou, Mike Khan, et al.
Infection and Immunity
|
September 30, 2015
CD8+ T cell exhaustion, suppressed gamma interferon production, and delayed memory response induced by chronic Brucella melitensis infection
Marina Durward-Diioia, Jerome Harms, Mike Khan, et al.
Infection and Immunity
|
May 9, 2018
Brucella Peptide Cross-Reactive Major Histocompatibility Complex Class I Presentation Activates SIINFEKL-Specific T Cell Receptor-Expressing T Cells
Jerome S Harms, Mike Khan, Cherisse Hall, et al.
Plos Pathogens
|
December 17, 2013
Brucella induces an unfolded protein response via TcpB that supports intracellular replication in macrophages
Judith A Smith, Mike Khan, Diogo D Magnani, et al.
Cancers
|
October 29, 2020
Safety, Efficacy and Pharcacokinetics of Targeted Therapy with The Liposomal RNA Interference Therapeutic Atu027 Combined with Gemcitabine in Patients with Pancreatic Adenocarcinoma. A Randomized Phase Ib/IIa Study
Beate Schultheis, Dirk Strumberg, Jan Kuhlmann, et al.
Annals of Clinical Biochemistry
|
January 10, 2016
Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays
Anne Reiman, Sarojini Pandey, Kate L Lloyd, et al.
Page
of 2